monique

👩‍🎓🎬✈️💕🇺🇸

[monique @monique__27]

@californiapost It only cost $20-$25 to get me a full battery of energy. I think most I paid at peak time was like $29

[monique @monique__27]

It is hot AF outside. 🫠

[monique @monique__27]

@Mr_Derivatives $ABCL in my opinion (NFA)

[AbCellera @AbCelleraBio]

AbCellera Announces Positive Top-Line Phase 2 Clinical Trial Results for ABCL635, Demonstrating Significant Reduction in Frequency and Severity of Vasomotor Symptoms and a Favorable Tolerability Profile https://t.co/SaKBMfviO7

[AbCellera @AbCelleraBio]

AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026 https://t.co/iKiCXMLGZe

[monique @monique__27]

Went to a concert last weekend saw a lot of girls with Botox , fillers and lip injections. It looks weird AF in person.

[monique @monique__27]

@MacroCRG Same

[AbCellera @AbCelleraBio]

AbCellera Announces Collaboration with Vertex to Discover Multispecific T-Cell Engagers for Autoimmune Diseases and Other Conditions https://t.co/UojKXosyvo

[monique @monique__27]

First the $JAZZ deal now $VRTX , I need to scoop up some more $ABCL I know this bad boy is going to run up just a matter of time. (NFA)

[Elijah @carrr2015]

🚀 $ABCL635 Phase 2 Could Be The Catalyst That Changes Everything
The biggest catalyst for $ABCL is approaching:

🧬 ABCL635 Phase 2 data

Why investors are watching:

✅ NK3R-targeted therapy
✅ Positive Phase 1 safety signals
✅ Potential long-duration dosing
✅ Large menopause symptom market opportunity

A successful Phase 2 could shift the narrative:

From antibody platform ➡️ clinical-stage biotech

The next milestone could redefine $ABCL.

👀 Watching closely.

#ABCL #Biotech #Healthcare

[monique @monique__27]

$ABCL is going to be a big win ain’t it. Wow 🤩

[monique @monique__27]

@TheInsiderPaper lol random

[monique @monique__27]

Today was a good day in the stock market for me 😊

[monique @monique__27]

@HolySmokas $ABCL for sure it’s green while everything is red.

[Clark Report @CClarkReport]

Caitlin Clark deserves better

[monique @monique__27]

@rektfencer Biotech is doing pretty good today $ABCL is super green

[monique @monique__27]

I’m patiently waiting for $SPCX to go down a lot more to hop back in. I might not touch this till next year will see, just on the sidelines for now.

[monique @monique__27]

The market is red while $ABCL is green 💚 . $SPY $QQQ $GOOGL

[monique @monique__27]

Are we going to have a Biotech summer? 😄 $ABCL $JAZZ

[AbCellera @AbCelleraBio]

Jazz Pharmaceuticals and AbCellera Announce Collaboration to Discover Next-Generation T-cell Engaging Multispecific Antibodies https://t.co/ISSSHSyPVz